Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–130
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Physician-diagnosed COPD
Having been prescribed treatment with TRIXEO according to label and local market reimbursement criteria
Patients must be able and willing to read and to comprehend written instructions, and to comprehend and complete the questionnaires required by the protocol
After full explanation, patients must have signed an informed consent document indicating that they understand the purpose of and the procedures required for the study and are willing to participate in the study.
You may not be if
COPD due to α-1 antitrypsin deficiency
Previous treatment with any other triple fixed-dose combination during screening
Hospitalisation due to COPD exacerbation within the last 4 weeks prior to enrolment
Pregnancy or lactation period
Participation in an observational trial that might, in the investigator's opinion, influence the assessment for the current study, or participation in a randomised clinical trial in the last 30 days.
